Literature DB >> 28498442

Prognostic significance of altered miRNA expression in whole blood of OSCC patients.

Jutta Ries1, Christoph Baran1, Falk Wehrhan1, Manuel Weber1, Friedrich W Neukam1, Andrea Krautheim-Zenk1, Emeka Nkenke2.   

Abstract

Currently, there is a lack of blood markers for the detection of recurrent oral squamous cell carcinoma (OSCC). The present study aimed to investigate whether the aberrant expression of single microRNAs (miRNAs) in whole blood of patients could serve as a biomarker for persistent or recurrent OSCC. Whole blood of 2 groups of formerly treated OSCC patients was investigated by RT-qPCR for their circulating miRNA profiles. The R-OC group included patients with recurrence of OSCC (n=21) and the NR-OC group included patients without recurrence (n=21). Fold-changes and significance of the differences in miRNA expression levels between the groups were determined. A cut-off point (COP) for the discrimination between the R-OC and NR-OC groups was calculated and the significance between over/under expression of the miRNAs and the recurrence of malignancy was determined. Significant differences in the miRNA expression in whole blood of the R-OC and NR-OC groups were found. The levels of miR-3651 and miR-494 were significantly increased and the level of miR-186 was significantly decreased in whole blood of the R-OC patients (pmiR-3651=0.001, pmiR-494=0.003 and pmiR-186=0.001). By the determination of the COP, increased or decreased expression of the markers was significantly correlated to the recurrence of the disease. Altered expression of miR-494, miR-3651 and miR-186 appears to be associated with the recurrence of OSCC. The present study may form the basis for establishing a blood test as a minimally invasive method for the detection of the recurrence of OSCC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498442     DOI: 10.3892/or.2017.5639

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC).

Authors:  Hong-Yu Zhang; Jian-Hui Ma
Journal:  Cancer Manag Res       Date:  2020-11-10       Impact factor: 3.989

2.  Long Noncoding RNA ZFAS1 Promotes Progression of Oral Squamous Cell Carcinoma Through Targeting miR-6499-3p/CCL5 Axis.

Authors:  Xiaoyong Qiu; Chenxi Li; Hao Chen
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 3.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

4.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

5.  miR-23a-3p Regulates Runx2 to Inhibit the Proliferation and Metastasis of Oral Squamous Cell Carcinoma.

Authors:  Yu Ma; Jinbo Gao; Hongning Guo
Journal:  J Oncol       Date:  2022-03-18       Impact factor: 4.375

Review 6.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

7.  miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway.

Authors:  Yawei Liu; Litian Hu; Qinqiang Liu; Jing Ye; Jianping Zhang
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

Review 8.  Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.

Authors:  Ruma Dey Ghosh; Arun Pattatheyil; Susanta Roychoudhury
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

9.  An Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells.

Authors:  Daniel J Browne; Jamie L Brady; Ashley J Waardenberg; Claire Loiseau; Denise L Doolan
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

10.  Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients.

Authors:  Yu Zhang; Qingjian Ye; Junxian He; Peigen Chen; Jing Wan; Jing Li; Yuebo Yang; Xiaomao Li
Journal:  Biomed Res Int       Date:  2020-02-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.